Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Kit for diagnosing acute myelocytic leukemia

A technology for acute myeloid and leukemia, applied in the field of kits for diagnosing acute myeloid leukemia, can solve problems such as death, and achieve the effects of reducing false positive rate, improving detection sensitivity and specificity

Inactive Publication Date: 2012-08-22
SUZHOU UNIV
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, standard chemotherapy can achieve a complete remission (CR) rate of about 70-80%, but most of the patients after CR will eventually relapse, and even some patients are difficult to achieve CR and become refractory leukemia, and the treatment is ineffective and dies

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Kit for diagnosing acute myelocytic leukemia
  • Kit for diagnosing acute myelocytic leukemia
  • Kit for diagnosing acute myelocytic leukemia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Embodiment one: the fluorescent RT-PCR method that diagnoses human AML to occur

[0031] (1) Material:

[0032] Trizol reagent was purchased from Invitrogen Company of the United States, Ologo dT, reverse transcription reaction solution, M-MLV reverse transcriptase, RNase inhibitor, dNTPs, SYBR Green polymerase chain reaction system, and PCR buffer were purchased from Fermentas Company of the United States, ABI 7500 The fluorescence quantitative system is a product of Applied Biosystems, USA.

[0033](2) Primer design and synthesis:

[0034] Using the full-length cDNA sequence as a template, use Prime5 software to analyze the primer sites, and select the best combination based on the consideration of the genomic DNA sequence.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a kit for diagnosing acute myelocytic leukemia. The kit comprises a reverse transcription system and a PCR (Polymerase Chain Reaction) amplification system, and is characterized in that: the reverse transcription system comprises repetition T oligonucleotide Ologod T, reverse transcription reaction solution, an M-MLV reverse transcriptase, an RNA (Ribonucleic Acid) enzyme inhibitor and dNTPs (Deoxynucleotide Triphosphate), wherein the PCR amplification system comprises an SYBRGreen PCR system and a primer pair; the reverse transcription reaction solution comprises diethyl pyrocarbonate treated water and M-MLV reverse transcriptase buffer solution; the SYBRGreen PCR system comprises PCR buffer solution, template cDNA (complementary Deoxyribonucleic Acid), dNTPs and an SYBRGreen fluorescent dye; and the primer pair is one capable of amplifying human Lc3 synthetase beta3Gn-T5 and human beta-actin. According to the invention, a method for detecting expression of the Lc3 synthetase beta3Gn-T5 by using the SYBRGreen technology is constructed, and the kit capable of conveniently, accurately and sensitively diagnosing the acute myelocytic leukemia is provided.

Description

technical field [0001] The invention belongs to the field of biotechnology, and relates to a quantitative RT-PCR detection kit, in particular to a real-time fluorescent quantitative RT-PCR detection kit for human glycosyltransferase, Lc3 synthetase β3Gn-T5, which is a kind of reagent kit by reversing It is a kit for accurately and quantitatively detecting the mRNA expression of Lc3 synthetase β3Gn-T5 in the specimen by combining with real-time fluorescent quantitative PCR detection technology to obtain cDNA from the recorded (RT) mRNA sample. Background technique [0002] Tumor is a new organism formed by the body under the action of various carcinogenic factors, a certain cell in the local tissue loses its normal regulation of its growth at the gene level, resulting in abnormal clonal proliferation. It is generally believed that tumor cells are monoclonal, that is, all tumor cells in a tumor are descendants of a mutant cell. Tumors are generally divided into benign and mal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
Inventor 李云森王征王艳萍
Owner SUZHOU UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products